| For: | He L, Zhang C, Liu LL, Huang LP, Lu WJ, Zhang YY, Zou DY, Wang YF, Zhang Q, Yang XL. Development of a diagnostic nomogram for alpha-fetoprotein-negative hepatocellular carcinoma based on serological biomarkers. World J Gastrointest Oncol 2024; 16(6): 2463-2475 [PMID: 38994169 DOI: 10.4251/wjgo.v16.i6.2463] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i6/2463.htm |
| Number | Citing Articles |
| 1 |
Jing Xu, Lin Tan, Ning Jiang, Feng Zhang, Jinling Wang, Fengcheng Li, Jin Wang, Heng Li, Lichang Chen, Olivia Mezzetti, Wenyu Lin, Shasha Li, Yufeng Gao. Integrating GPC3 with Other Biomarkers to Improve the Diagnosis of Early-Stage Liver Cancer. Pathogens 2025; 14(12): 1189 doi: 10.3390/pathogens14121189
|
| 2 |
Katrina Li, Brandon Mathew, Ethan Saldanha, Puja Ghosh, Adrian R. Krainer, Srinivasan Dasarathy, Hai Huang, Xiyan Xiang, Lopa Mishra. New insights into biomarkers and risk stratification to predict hepatocellular cancer. Molecular Medicine 2025; 31(1) doi: 10.1186/s10020-025-01194-6
|
| 3 |
Hu Rui, Ni Yueqin, Wang Wei, Li Bangtao, Xiao Li. Combining AFP, PIVKA-II, and GP73 has diagnostic utility for hepatitis B-associated hepatocellular carcinoma and is consistent with liver pathology results. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-92067-9
|
